Targeting cancer stem cells to suppress acquired chemotherapy resistance

S. J. Vidal, V. Rodriguez-Bravo, M. Galsky, C. Cordon-Cardo, J. Domingo-Domenech

Research output: Contribution to journalReview articlepeer-review


Acquired resistance has curtailed cancer survival since the dawn of the chemotherapy age more than half a century ago. Although the application of stem cell (SC) concepts to cancer captured the imagination of scientists for many years, only the last decade has yielded substantial evidence that cancer SCs (CSCs) contribute to chemotherapy resistance. Recent studies suggest that the functional and molecular properties of CSCs constitute therapeutic opportunities to improve the efficacy of chemotherapy. Here we review how these properties have stimulated combination strategies that suppress acquired resistance across a spectrum of malignancies. The clinical implementation of these strategies promises to rejuvenate the effort against an enduring challenge.

Original languageEnglish (US)
Pages (from-to)4451-4463
Number of pages13
Issue number36
StatePublished - Sep 4 2014


  • apoptosis and survival
  • cancer stem cells
  • chemotherapy
  • differentiation
  • quiescence
  • self-renewal

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Targeting cancer stem cells to suppress acquired chemotherapy resistance'. Together they form a unique fingerprint.

Cite this